All news on the topic: MSD

882
MSD and AstraZeneca halt nearly £2bn in UK multi-million-pound expansions
Big pharmaceutical companies have abandoned or paused nearly £2bn in planned UK investments so far this year, causing "suffering" to patients, as ministers prepare for discussions with Donald Trump amid a dispute over drug pricing.